QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
Dr. Catalona Responds to Stories and Studies About Use of PSA Testing and Treatments for Prostate Cancer In the following Questions and Answers, Dr. Catalona responds to questions he hears most often regarding PSA testing, early detection, and prostate cancer…
(This article is a portion of a paper on PSA screenings revised for QUEST) If there were no effective treatment for prostate cancer, early detection would not be important, but studies are showing that patients treated with a radical prostatectomy…
Several previous articles in QUEST and on the drcatalona.com website address postoperative radiotherapy, but recent reports have increased our knowledge, and this article supplements those previous ones. History In the past, we, and other researchers, analyzed 4-year studies of the…
Familial Prostate Cancer Screening Program Opens at Northwestern Memorial Hospital We are enrolling people with a family history of prostate cancer in research studies that aim to map the genetics of prostate cancer We have opened a Familial Prostate Cancer…
NCCN Guidelines For Early Detection My favorite Practice Guidelines for the treatment of prostate cancer (CaP) are prepared by the National Comprehensive Cancer Network (NCCN) group of medical centers, which are the 19 comprehensive centers of excellence for practice and…
One year to the day after Jim Carricks operation to remove his cancerous prostate, he ran the Boston Marathon. Racing isnt important to him. But his wife, three daughters, friends, business, and local community are. The Marathon was to show…
One of the big but unanswered questions about prostate cancers is: Which ones are aggressive and which ones are not? In a recent study, my research partners and I have found some answers that very likely will change the way…
Prostate cancer (CaP) is a complex disease involving multiple steps and pathways to the development of cancer. Each step involves one or more genetic changes. Family studies have found varying degrees of clustering of prostate cancer in certain families, suggesting…
(Is 98% rate of non-recurrence a realistic goal?) Why a patient’s column? This is not a doctors column. I am a patient of Dr. Catalona and a member of the URF Board. This column attempts to provide a patients perspective…
Each year, Dr. Catalona and his research collaborators deliver their research findings at the American Urological Association (AUA) annual meeting. In the last issue of QUEST, we summarized findings from recent research projects of Dr. Catalona and his collaborators. The…
"*" indicates required fields
